Red light therapy marketing that fills sessions without triggering FDA warning letters

Red light therapy devices are FDA 510(k) cleared for specific indications (certain acne treatments, certain hair growth treatments, certain musculoskeletal pain applications), not FDA approved. The distinction matters in marketing: cleared and approved have different regulatory meanings, and using "approved" when a device is only "cleared" creates compliance risk. Off-label uses of red light therapy (general skin health, athletic recovery, sleep, mitochondrial function, longevity) are marketed under the FDA's General Wellness Policy without making medical treatment claims. The compliant claim language uses "may support" rather than "treats" or "cures."

Medical claims about red light therapy must match the specific FDA 510(k) clearance of the device used and must be substantiated by the manufacturer's clinical data. General red light therapy claims (red light "reduces inflammation," "improves cellular function," "reverses aging") typically cannot be made as medical treatment claims because they exceed FDA structure/function language. The FTC has flagged the red light therapy industry for systematic overclaiming, particularly on body contouring, weight loss, hair growth, and anti-aging. The Spectra Therapy LLC and Dr. Joel Kaplan warning letters set the enforcement precedent.

Red light therapy ads run inside Meta's Special Ad Category for Health and Wellness. The ads must comply with Meta's Personal Health policy (no "you" framing for medical conditions), targeting is restricted (no detailed interests, no lookalike audiences from sensitive custom audiences), and creative cannot show before-and-after transformation imagery that implies a personal medical condition. Compliant red light therapy creative leads with mechanism, founder POV, clinical environment, or lifestyle framing. The funnel routes to a landing page with E-E-A-T signals (credentialed practitioner, citations, contact information) to clear Quality Score requirements.

Red light therapy is a profitable business when the unit economics work. Session pricing typically runs $75 to $125 at retail, with packages and memberships bringing the effective rate down to $50 to $90 per session. Memberships at $150 to $400 per month for multi-session access, or $300 to $1,000 per month inside multi-modality biohacking and recovery stacks, drive the bulk of the lifetime value. The break-even math works when session frequency stays above 4 to 6 visits per month per member. Multi-modality studios typically outperform single-modality RLT clinics on unit economics.

Photobiomodulation (PBM) is the scientific term for what consumer marketing typically calls red light therapy or low-level laser therapy (LLLT). PBM uses specific wavelengths of red and near-infrared light (typically 630nm, 660nm, 810nm, and 850nm) to influence cellular function, particularly mitochondrial activity. The FDA has 510(k) cleared specific PBM devices for specific indications (acne, hair growth, certain musculoskeletal pain). Off-label PBM applications (skin health, recovery, sleep, longevity) are marketed under the FDA's General Wellness Policy. Using the term "photobiomodulation" rather than "red light therapy" signals clinical literacy to educated buyers and improves SEO ranking for the PBM keyword cluster.

Pricing varies by clinic size, single vs. multi-modality positioning, ad spend, and market. A typical single-location red light therapy clinic runs $2,000 to $5,000 per month in retainer plus a comparable ad spend budget, with hybrid retainer-plus-commission or performance-based pricing depending on the plan. Multi-modality biohacking and recovery studios that include red light as part of a broader stack typically run higher budgets matched to higher member LTV. Raging Agency does not publish a generic price sheet because RLT clinics have widely different economics depending on whether RLT is the headline service or a cross-sell modality.